CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $42,625,000 | -0.1% | 825,103 | -52.1% | 0.01% | +7.7% |
| Q2 2022 | $42,651,000 | +5.6% | 1,721,194 | +6.8% | 0.01% | +30.0% |
| Q1 2022 | $40,388,000 | -8.9% | 1,610,991 | +32.2% | 0.01% | -9.1% |
| Q4 2021 | $44,355,000 | +146.3% | 1,218,188 | +15.7% | 0.01% | +120.0% |
| Q3 2021 | $18,012,000 | +102.0% | 1,053,324 | +58.2% | 0.01% | +150.0% |
| Q2 2021 | $8,918,000 | -74.3% | 666,013 | -1.6% | 0.00% | -77.8% |
| Q1 2021 | $34,691,000 | -42.4% | 677,040 | -30.4% | 0.01% | -50.0% |
| Q4 2020 | $60,229,000 | +56.9% | 972,683 | +38.9% | 0.02% | +38.5% |
| Q3 2020 | $38,378,000 | +216.5% | 700,333 | +232.3% | 0.01% | +225.0% |
| Q2 2020 | $12,127,000 | -4.6% | 210,743 | -33.4% | 0.00% | -20.0% |
| Q1 2020 | $12,706,000 | +98.3% | 316,233 | +95.2% | 0.01% | +150.0% |
| Q4 2019 | $6,406,000 | +526.8% | 161,968 | +7.5% | 0.00% | – |
| Q3 2019 | $1,022,000 | -32.0% | 150,611 | -6.9% | 0.00% | – |
| Q2 2019 | $1,504,000 | -27.3% | 161,723 | +8.5% | 0.00% | -100.0% |
| Q1 2019 | $2,070,000 | +31.8% | 148,988 | +3.6% | 0.00% | 0.0% |
| Q4 2018 | $1,570,000 | -8.8% | 143,834 | +5.7% | 0.00% | 0.0% |
| Q3 2018 | $1,721,000 | +232.9% | 136,127 | +246.5% | 0.00% | – |
| Q2 2018 | $517,000 | -22.8% | 39,282 | -20.3% | 0.00% | – |
| Q1 2018 | $670,000 | +45.0% | 49,265 | -36.6% | 0.00% | – |
| Q4 2017 | $462,000 | -46.2% | 77,660 | -32.9% | 0.00% | – |
| Q3 2017 | $859,000 | -17.1% | 115,762 | +4.6% | 0.00% | – |
| Q2 2017 | $1,036,000 | -41.9% | 110,692 | -54.8% | 0.00% | -100.0% |
| Q1 2017 | $1,784,000 | -1.5% | 245,048 | +0.1% | 0.00% | 0.0% |
| Q4 2016 | $1,811,000 | +522.3% | 244,782 | +408.6% | 0.00% | – |
| Q3 2016 | $291,000 | +5720.0% | 48,131 | +7601.0% | 0.00% | – |
| Q2 2015 | $5,000 | -93.8% | 625 | -94.1% | 0.00% | – |
| Q1 2015 | $80,000 | – | 10,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |